Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 4, 2007, Pages 368-376

  Hartsell, William F ^a,h   Scott, Charles B ^b   Dundas, George S ^c   Mohiuddin, Mohammed ^d   Meredith, Ruby F ^e   Rubin, Philip ^f   Weigensberg, Irving J ^g  

^a Lutheran General Cancer Center   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^g Advocate Good Samaritan Hospital ^*

^h Advocate Good Samaritan Hospital   (United States)

Author keywords

Interleukin 6; Radiation pneumonitis; Serum markers; Surfactant apoprotein

Indexed keywords

APOPROTEIN; BIOLOGICAL MARKER; INTERLEUKIN 1; INTERLEUKIN 6; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE TOXICITY; ADULT; ARTICLE; CANCER STAGING; CLINICAL TRIAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INOPERABLE CANCER; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INTERLEUKIN-6; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RESPIRATORY FUNCTION TESTS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 34548429214     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000260950.44761.74     Document Type: Article

References (46)

1. Choi NC, Kanarek DJ, Kazemi H. Physiologic changes in pulmonary function after thoracic radiation for patients with lung cancer and role of regional pulmonary function studies in predicting postradiotherapy pulmonary function before radiotherapy. Cancer Treat Symp. 1985;2:119-130.
2. Fazio F, Pratt TA, McKenzie CG, et al. Improvement in regional ventilation and perfusion after radiotherapy for unresectable carcinoma of the bronchus. Am J Radiol. 1979;133:191-200.
3. Brooks BJ Jr, Siefter EJ, Walsh TE, et al. Pulmonary toxicities with combined modality therapy for limited stage small-cell lung cancer. J Clin Oncol. 1986;4:200-209.
4. Carcelen A, Zaharia M, Carceres E, et al. Pulmonary functions tests during adjuvant lung irradiation for osteogenic sarcoma. Cancer Treat Rep. 1980;64:701-703.
5. Kaufman J, Gunn W, Hartz AJ, et al. The pathophysiologic and roentgenologic effects of chest irradiation in breast carcinoma. Int J Rad Onc Biol Phys. 1986;12:887-893.
6. Cionini L, Pacini P, DePaoloa E, et al. Respiratory function tests after mantle irradiation in patients with Hodgkin's disease. Acta Radiol. 1984;23:401-409.
7. Groth S, Zaric A, Sorensen PB, et al. Regional lung function impairment following post-operative radiotherapy for breast cancer using direct or tangential field techniques. Br J Radiol. 1986;59:445-451.
8. Watchie J, Coleman CN, Raffin TA, et al. Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1987;13:517-524.
9. Do Pico GA, Wiley AL, Rao P, et al. Pulmonary reaction to upper mantle radiation therapy for Hodgkin's disease. Chest. 1979;75:688-692.
10. Benoist MR, Lemerle J, Jean R, et al. Effects on pulmonary function of whole lung radiation for Wilms' tumor in children. Thorax. 1982;37:175-180.
11. Loyd JE, Bolds JM, Sheller JR, et al. Acute effects of thoracic irradiation on lung function and structure in awake sheep. J Appl Physiol. 1987;62:208-218.
12. Down JD. The nature and relevance of late lung pathology following localized irradiation of the thorax in mice and rats. Br J Cancer. 1986;53(suppl 7):330-332.
13. Karvonen RL, Fernandez-Madrid F, Maughan RL, et al. An animal model of pulmonary radiation fibrosis with biochemical, physiologic, immunologic, and morphologic observations. Radiat Res. 1987;111:68-80.
14. Mahler DA, Wells CK, Weinberg DH, et al. The evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580-586.
15. Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea. Chest. 1984;85:751-758.
16. Moldofsky P, Rubenstein J, Richeter M, et al. Quantitative lung scans for prediction of post-radiotherapy pulmonary functions. Clin Nucl Med. 1988;13:644-646.
17. Rubenstein JH, Richter MP, Moldofsky PJ, et al. Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing. Int J Radiat Oncol Biol Phys. 1988;15:83-89.
18. BMDP. Statistical Software Manual for Release, 7. Berkley, CA: University of California Press; 1992.
19. AnswerTree, version 2.0. SPSS; 2000.
20. Gross NJ. Pulmonary effects of radiation therapy. Ann Intern Med 1977;86:81-92.
21. Taw I, Hartsell W, Rubin D. Radiation toxicity of the lungs. Clin Pulmonary Med. 1995;2:295-302.
22. Curran WJ, Moldofsky PJ, Solin LJ. Analysis of the influence of elective nodal irradiation on post-irradiation pulmonary function. Cancer. 1990;65:2488-2493.
23. Halme M, Hallman M, Ruotsalainen T, et al. Tumour response and radiation-induced lung injury in patients with recurrent small cell lung cancer treated with radiotherapy and concomitant interferon-alpha. Lung Cancer. 1999;23:39-52.
24. Choi NC, Kanarek DJ, Kazemi H. Factors influencing physiological changes of pulmonary functions as a result of thoracic radiotherapy in lung cancer: Proceedings of the Annual Meeting of the American Society of Therapeutic Radiation and Oncology, Nov, 1986. Int J Radiat Oncol Biol Phys. 1986;12(suppl):112.
25. Mah K, Van Dyk J, Keane T, et al. Acute radiation-induced pulmonary damage: a clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys. 1987;13:179-188.
26. Rubin P, Shapiro DL, Finklestein JN, et al. The early release of surfactant following lung irradiation of alveolar type II cells. Int J Radiat Oncol Biol Phys. 1980;6:75-77.
27. Rubin P, Siemann DW, Shapiro DL, et al. Surfactant release as an early measure of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 1983;9:1669-1673.
28. Okazaki I, Miura K, Kobayashi Y, et al. Serum type III procollagen peptides: indicator for pulmonary fibrosis. Keio J Med. 1986;35:107-115.
29. Thornton SC, Walsh BJ, Bennett S, et al. Both in vitro and in vivo irradiation are associated with induction of macrophage-derived fibroblast growth factors. Clin Exp Immunol. 1996;103:67-73.
30. Redlich CA, Gao X, Rockwell S, et al. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol. 1996;157:1705-1710.
31. Khan MA, Hill RP, Van Dyk J. Partial volume rat lung irradiation: an evaluation of early DNA damage. Int J Radiat Oncol Biol Phys. 1998;40:467-476.
32. O'Brien-Ladner A, Nelson ME, Kimler BF, et al. Release of interleukin-1 by human alveolar macrophages after in vitro irradiation. Radiat Res. 1993;136:37-41.
33. Rubin P, Johnston CJ, Williams JP, et al. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys. 1995;33:99-109.
34. Gridley DS, Loredo LN, Slater JD, et al. Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor. Cancer Detect Prev. 1998;22:20-29.
35. Epperly MW, Travis EL, Sikora C, et al. Magnesium superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: modulation of irradiation-induced mRNA for IL-I, TNF-alpha, and TGF-beta correlates with delay of organizing alveolitis/fibrosis. Biol Blood Marrow Transplant. 1999;5:204-214.
36. Hong JH, Chiang CS, Tsao CY, et al. Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation. Int J Radiat Biol. 1999;75:1421.
37. Brach MA, Gruss HJ, Kaisho T, et al. Ionizing radiation induces expression of interleukin 6 by human fibroblasts involving activation of nuclear factor-kappa B. J Biol Chem. 1993;268:8466-8472.
38. Tartakovsky B, Goldstein O, Krautghamer R, et al. Low doses of radiation induce systemic production of cytokines: possible contribution to leukemogenesis. Int J Cancer. 1993;55:269-274.
39. Claude L, Perol D, Ginestet C, et al. Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy. Radiother Oncol. 2004;71:175-181.
40. Hernando ML, Marks LB, Bentel GC, et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys. 2001;51:650-659.
41. Chen Y, Williams J, Ding I, et al. Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol. 2002;12(suppl 1):26-33.
42. Chen Y, Rubin P, Williams J, et al. Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2001;49:641-648.
43. De Jaeger K, Seppenwoolde Y, Kampinga HH, et al. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58:1378-1387.
44. Barthelemy-Brichant N, Bosquee L, Cataldo D, et al. Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiat Oncol Biol Phys. 2004;58:758-767.
45. Fu XL, Huang H, Bentel G, et al. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys. 2001;50:899-908.
46. Anscher MS, Marks LB, Shafman TD, et al. Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56:988-995.